Replies to post #212761 on Biotech Values

[DewDiligence]

NVTA sells 12.78M* shares@$4.50—a 36% discount to Monday’s close:

https://finance.yahoo.com/news/invitae-announces-pricing-public-offering-100000318.html

*Assuming exercise of underwriter’s option.

[DewDiligence]

NVTA acquires—(private)—ArcherDx for ~$900M in cash+stock + CVR:

https://www.prnewswire.com/news-releases/invitae-and-archerdx-to-create-a-global-leader-in-comprehensive-cancer-genetics-and-precision-oncology-301080846.html

ArcherDX had recently filed to IPO.